<DOC>
	<DOCNO>NCT01556828</DOCNO>
	<brief_summary>The goal study identify genetic change associate initiation , progression , treatment response response cutaneous hematologic disorder use recently develop high-throughput sequence technology . The improved understanding genetic change associate cutaneous hematologic disorder may lead improved diagnostic , prognostic therapeutic option disorder .</brief_summary>
	<brief_title>Analysis Cutaneous Hematologic Disorders High-Throughput Nucleic Acid Sequencing</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<criteria>18 year age old Patient meet clinical and/or pathologic criterion cutaneous hematologic disorder examine . Patient willing provide skin biopsy five 10 mL tube peripheral blood . Less 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>